- Home
- FICO vs GH Comparison
FICO vs GH Comparison
Compare FICO & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FICO | GH |
|---|---|---|
| Founded | 1956 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3B | 20.6B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FICO | GH |
|---|---|---|
| Price | $1,160.01 | $168.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 19 |
| Target Price | ★ $1,689.92 | $119.79 |
| AVG Volume (30 Days) | 383.8K | ★ 1.9M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.78 | 6.74 |
| EPS | ★ 28.12 | N/A |
| Revenue | ★ $1,032,475,000.00 | $982,021,000.00 |
| Revenue This Year | $27.28 | $33.30 |
| Revenue Next Year | $16.97 | $28.27 |
| P/E Ratio | $41.31 | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $870.01 | $53.40 |
| 52 Week High | $1,998.01 | $176.58 |
Technical Indicators
Market Signals| Indicator | FICO | GH |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 59.33 |
| Support Level | $1,067.18 | $152.64 |
| Resistance Level | $1,329.48 | $174.19 |
| Average True Range (ATR) | 47.33 | 6.61 |
| MACD | 9.92 | -0.20 |
| Stochastic Oscillator | 89.70 | 67.79 |
Price Performance
Historical ComparisonAbout FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.